Inventor · disambiguated record
Young Goo Jin
Also filed as: JIN YOUNG G · JIN YOUNG GOO
6 granted patents·2 pending applications·45 citations·filing 2002–2009
78Inventor score
Top patents by PatentIndex Score
8 records- 0188US7291638B23-amido-1,2-benzoisoxazole derivatives, process for preparation, and use thereofDONG WHA PHARM IND CO LTD·Filed 2002·Granted Nov 6, 2007·31 cites·6 claims
- 0286US8008329B2Method of treating or preventing osteoporosis comprising administering to a patient in need thereof an effective amount of pharmacuetical composition comprising benzamidine derivative or it's salt, and bisphosphonateDONG WHA PHARM CO LTD·Filed 2009·Granted Aug 30, 2011·7 cites·28 claims
- 0379US7943646B2Benzamidine derivative, process for the preparation thereof and pharmaceutical composition comprising sameDONG WHA PHARM CO LTD·Filed 2007·Granted May 17, 2011·3 cites·18 claims
- 0474US8178688B2Benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the sameLEE JIN SOO·Filed 2005·Granted May 15, 2012·4 cites·24 claims
- 0552US8039635B2N-hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl) phenoxy]pentoxy} benzamidine 2 ethansulfonic acid salt, process for the preparation thereof and pharmaceutical composition comprising the sameDONG WHA PHARM CO LTD·Filed 2008·Granted Oct 18, 2011·0 cites·10 claims
- 0647US2010249402A1Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition for preventing or treating osteporosis comprising the sameDONG WHA PHARM CO LTD·Filed 2008·Application pending·0 cites
- 0746US7585979B2Process for preparing N-hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)-phenoxy]-pentoxy}-benzamidineDONG WHA PHARM IND CO LTD·Filed 2005·Granted Sep 8, 2009·0 cites·7 claims
- 0839US2009176846A1N-hydroxy-4- {5- [4- (5-isopropyl-2-methyl-1, 3-thiazol-4-yl) phenoxy] pentoxy} benzamidine 2 methanesulfonic acid saltRYU JEI MAN·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →